A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tirzepatide
Related studies linked through entity extraction aliases.
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide in Participants With Impaired Liver Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2